The author presents his experience in utilizing homograft sclera for tympanic-membrane reconstruction. In-vitro and in-vivo studies suggest that sclera is an excellent material for tympanic-membrane grafting and has an acceptably high graft-take rate.
The use of tympanic-membrane-grafting materials dates back to 1640, when Marcus Banzar ' reported his experiences in attempting to repair a tympanic-membrane perforation by using a piece of pig's bladder. Little mention of plastic repair of the tympanic membrane was then made until the reports of Berthold. In 1879 he described a successful new operation, "Myringoplastik,"2 in which he freshened the edges of a tympanic-membrane perforation and placed a thin patch of court plaster over the defect. Three days later this patch was replaced by a split-thickness skin graft obtained from the forearm. Berthold subsequently reported experimental work with chicken-egg membrane and rabbit cornea.' Although he continued to perform myringoplasties, his efforts apparently did not lead to wide acceptance of the procedure. Ely," in 1880, and Tangeman;' in 1883, reported their attempts at myringoplasty without clarifying their postoperative results. Reports of myringoplastic surgery then disap-Ear, Nose, & Throat Journal peared from the medical literature for about 60 years. In 1950, Moritz" first described the use of pedicle skin flaps to construct a closed middle-ear cavity. Zollner," in 1951, and Wullstein," in 1952, did much to revive the thinking about Berthold's myringoplasty and advocated procedures that provided firm protection for the round window as well as allowing for reconstruction of the sound-pressure transformer for the oval window." Wullstein coined the term "tympanoplasty" for this concept of ear surgery. The grafting of the tympanic membrane in these tympanoplastic procedures de-'pended on the use of free split-or full-thickness skin grafts. Improvements in audiometry and surgical techniques, as well as the advent of antibiotics and the surgical microscope, were contributing factors to the success in plastic repair of the tympanic membrane and in reconstruction of the middle-ear sound-conducting mechamsm.
In this country, Howard House,"? in 1953, contmued reported on the use of thinned full-thickness skin grafts from the postauricular area. Wright 1 1 reported on the use of variable-thickness split grafts from different donor sites. In 1956, Sooy'? described the use of a pedicle graft of canal-wall skin to close marginal tympanicmembrane perforations. In 1958, Holewinski.':' utilized a cadaveric corneal material in myringoplasty. Free grafts of skin from the wall of the external auditory canal were introduced independently by William House and Sheehy!" and by Piester .15 In 1960, Shea16 introduced the vein graft as connective-tissue-grafting material and Ts'ao and colleagues'? reported the use of amniotic membrane. In 1961, Storrs'" advocated the use of temporalis fascia as an underlay grafting material in myringoplasty. Since then, temporalis fascia has gained wide acceptance for closure of tympanic-membrane perforations. Sheehy and others l 9 -2 2 have popularized the use of temporalis fascia combined with an overlay of free canal-wall skin graft placed lateral to the tympanic-membrane remnant.
Other reports have indicated that a combination of underlay and overlay fascia grafting known as double-fascia grafting also offer consistently good long-term results;" as do perichondrial grafts/ 4 loose areolar connective tissue;" and homograft procedures.P-'? These reports are listed in Table 1 .
OTHER TECHNIQUES
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For more complete details, consull package Insert or Scherlng literature avatlable from your Scherlng Representative or Professional Services Department, Scherlng Corporation, Kenilworth, New Jersey 07033. In attempting to answer this question, Strahan and colleagues-" analyzed a series of 483 patients undergoing both underlay and overlay graft myringoplasties. These investigators found that fascia and perichondrium, both metabolically less active tissues, were superior to vein, a metabolically more active tissue, regardless of whether a medial or lateral graft was used. Many otologists today believe that connective-tissue grafts are superior to skin grafts. Perkins-? refers to these tissue grafts as "biomaterials" because most otologists use tissue that is no longer alive, having been altered by drying or chemical denaturing. What is sought in these "biomaterials" is a collagen matrix that will act as a scaffold upon which the tympanic-membrane perforation will close.
Bloom and Fawcett!' classify connective tissue in various ways ( Table 2) The so-called dense and loose connective tissues differ in the amount of fibrous matrix in proportion to the cellular and ground-substance content. The classification of dense connective tissues is often further subdivided into dense irregular and dense regular connective tissues, depending on whether the fibrous component appears randomly or systematically arranged. Dense irregular connective tissues are perhaps some of the sturdiest in the body. Human sclera, a dense irregular connective tissue that contains elastic fibers (Figure 1 ), would seem a suitable tympanic-membrane-grafting material, with its high density, good tensile strength, and previously demonstrated low antigenicity.32 The use of sclera as a grafting material is not new. Ophthalmologists have long employed it surgically. In 1950, Paufique and co-workers:" .reported the first successful use of a scleral homograft in man. Subsequent usage of preserved homograft sclera has included the reinforcement of thin sclera in retinal-detachment surgery, 'treatment of scleromalacia perforans, correction of eyelid ptosis, and the treatment of other ophthalmic pathologic entities for which scleroplasty is necessary.
In 1958, King:" pointed out that sclera could be preserved by dehydration in glycerin or by freeze-drying. It could then be stored indefinitely at room temperature in vacuum-sealed tubes. In 1960, Payrau and Pouliquen" introduced desiccation by silica. Since these initial publications various other methods for preserving homograft sclera have been advocated, although it appears to make little difference which method is employed as long as the collagen structure is not altered and the tissues remain sterile.i"
AUTHOR'S TECHNIQUE
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It is hypothesized that a major reason for tympanic-membrane-graft failure is related to the fact that epithelialization of some scaffold materials is not completed before breakdown of the tissue scaffold. Factors that affect graft * Transilwrap Company of Atlanta, Inc.,3616 McCall Place, Doraville, Ga. breakdown center around proteolysis of the graft and are augmented by infection. In an attempt to define the role that organisms play in graft proteolysis, cultures were obtained from external-auditory-canal packings removed from the innermost portion of the canals three weeks after routine tympanoplastic surgery.
Many of these cultures were mixed, but Proteus vulgaris was the most common isolate, either as a pure culture or in combination with other bacterial organisms ( Table 3 ). Sections of preserved human sclera, fascia, and perichondrium of similar dimensions were then incubated in pure-broth cultures of each of the previously described bacterial organisms. The cultures were observed weekly for any gross change in the human tissue. At four weeks, the specimens were removed for histologic study. Examination of the gross specimens revealed a marked destruction and fragmentation of the perichondrium and fascia, while the sclera maintained its structural integrity. Pre-and postincubation histologic studies of temporal fascia (Figures 2  and 3 ) demonstrate the breakdown of the collagen matrix. A similar change is noted in the preand postincubation histology of human perichondrium (Figures 4 and 5 ). In the case of the human sclera ( Figure 6 ), there is still discernible architecture in the postincubation specimenindicating that the collagen matrix appears to have remained intact to a greater extent than in the other tissues. The histologic study compares very well with gross observations of the various tissues after four weeks of incubation with the bacteria. The fate of the scleral graft should be similar to that of other connective-tissue grafts. This is borne out in a histologic study performed on a scleral-graft tympanoplasty that was unsuccessful. A patient who had undergone a type-I scleral-graft tympanoplasty one year before the study had a reperforation of his tympanic membrane in the region of the previous graft. At the time of repeat surgery, a biopsy of the previously grafted area was obtained.
As may be seen in Figure 7 , the dense collagenous matrix of the sclera was replaced by a less fibrous tissue with marked cellularity and surface re-epithelialization.
CLINICAL EXPERIENCE
Our first clinical experience with sclera was in 1970, when the material was used for facial slings in patients with seventh-nerve paralysis. Impressed with its strength and low antigenicity, we then conceived the idea of homograft scleral tympanic-membrane reconstruction. Our first scleral graft, performed in 1974, was a success, but the method was subsequently employed in a sporadic fashion for previous fasciagraft failures. Our overall results were quite good. We first reported our experiences with homograft-sclera myringoplasty in 1977. 31 At that time we had 60 cases, with 58 initial takes in a maximum of 18 months' follow-up. After three years' follow-up one graft broke down, giving a three-year take rate of 57 of the original 60 cases.
Although all postoperative tympanograms showed slightly less compliance than that for repair with other connective-tissue-grafting materials, preoperative and postoperative audiometric testing has shown results comparable with those for procedures done with standard connective-tissue grafts, with a primary take rate of approximately 95 percent. We believe that homograft sclera offers some advantages over other materials used in myringoplasty (Table 4 ). Sclera is substantial enough to allow slow healing and resists bacterial breakdown. The preserved homograft sclera is easy to work with, and its consistency may be altered. At the time of surgery the graft is examined for texture; if a slightly stiffer graft is desired, the sclera may be soaked in 95 percent ethyl alcohol for 10 minutes.
Since the time of our preliminary report a number of otologists have been using sclera with pleasing results, as typified by the 1978 report of Thawley and Stroud. 38 0 BIBLIOGRAPHY
